PETVIVO HOLDINGS, INC. Financials PetVivo Holdings, Inc.
Equities
PETV
US7168174081
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.83 USD | 0.00% |
|
+1.26% | -21.70% |
| 04-11 | PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index | CI |
| 04-10 | PetVivo Holdings, Inc. announced that it has received $0.3 million in funding from A.L. Sarroff Management, LLC | CI |
Valuation
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 71.35 | 19.94 | 29.8 | 13.92 | - |
| Enterprise Value (EV) 1 | 71.35 | 19.94 | 29.8 | 13.92 | 13.92 |
| P/E ratio | -18.4 x | -3.58 x | -3.24 x | -0.86 x | -1.32 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 173 x | 32.5 x | 5.23 x | 1.56 x |
| EV / Revenue | - | 173 x | 32.5 x | 5.23 x | 1.56 x |
| EV / EBITDA | - | - | - | - | - |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 6,796 | 9,775 | 10,838 | 16,770 | - |
| Reference price 2 | 10.50 | 2.040 | 2.750 | 0.8300 | 0.8300 |
| Announcement Date | 21-06-29 | 22-06-24 | 23-06-29 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.1156 | 0.9172 | 2.66 | 8.9 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | - | -5.057 | -8.733 | -12.12 | - |
| Operating Margin | - | -4,374.54% | -952.23% | -455.67% | - |
| Earnings before Tax (EBT) 1 | - | -5.015 | -8.718 | -12.45 | -9.8 |
| Net income 1 | -3.523 | -5.015 | -8.718 | -12.45 | -9.8 |
| Net margin | - | -4,338.61% | -950.5% | -468.19% | -110.11% |
| EPS 2 | -0.5700 | -0.5700 | -0.8500 | -0.9700 | -0.6300 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 21-06-29 | 22-06-24 | 23-06-29 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.00498 | 0.051 | 0.0555 | 0.0582 | 0.2233 | - | 0.1256 | - | 0.35 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT | -1.103 | -1.658 | -1.777 | -1.966 | -2.12 | - | -2.329 | - | - |
| Operating Margin | -22,155.82% | -3,250.29% | -3,204.11% | -3,379.9% | -949.29% | - | -1,854.28% | - | - |
| Earnings before Tax (EBT) 1 | -1.105 | -1.642 | -1.777 | -1.965 | -2.112 | - | -2.329 | - | -4.961 |
| Net income 1 | -1.105 | -1.642 | -1.777 | -1.965 | -2.112 | -2.312 | -2.329 | -2.894 | -4.961 |
| Net margin | -22,198.19% | -3,219.86% | -3,203.68% | -3,378.77% | -945.71% | - | -1,854.28% | - | -1,417.43% |
| EPS 2 | -0.1300 | -0.1700 | -0.1900 | -0.2000 | -0.2100 | -0.2300 | -0.2100 | -0.2500 | -0.3200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 21-11-15 | 22-02-10 | 22-06-24 | 22-08-11 | 22-11-10 | 23-02-09 | 23-06-29 | 23-08-10 | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 21-06-29 | 22-06-24 | 23-06-29 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.83
USD
Average target price
5
USD
Spread / Average Target
+502.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.70% | 13.92M | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.8B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B |
- Stock Market
- Equities
- PETV Stock
- Financials PetVivo Holdings, Inc.
